You are here: Industry Insights > Risk management

News List

Risk Management in Pharmaceutical Industry Muhammad Asim Niazi
February 19, 2024
Risk management is a critical aspect of any industry, used as a baseline activity to identify and mitigate risk in their over processes.
Update on ICH Q9(R1) Quality Risk Management Muhammad Asim Niazi
August 23, 2023
In collaboration with the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use – ICH, the FDA has updated the 2006 version of Q9 Quality Risk Management.
Strengthened guidance on follow-up and risk management for ATMP developers europeanpharmaceuticalreview
April 29, 2019
Guideline to streamline procedures and better address the specific requirements of ATMP developers published for consultation…
Free webinar: EU risk management for oncology medicines pharmafile
May 15, 2018
In our latest free webinar, listen to Dr William Richardson, Medical Advisor at NDA Group, speak on how to best implement the revised GVP module (V) concerning risk management in the interests of patients throughout the life-cycle of a medicine.
Risk Management Planning & Signal Management in Pharmacovigilance pharmafocusasia
May 14, 2018
Training Course on Risk Management Planning & Signal Management in Pharmacovigilance Not-To-Be Missed!
Free webinar – Rational EU risk management for oncology medicines pharmafile
May 07, 2018
It is timely to reflect on how we can best implement the revised GVP module (V) concerning risk management in the interests of patients throughout the life-cycle of a medicine.
FDB Releases Opioid Risk Management Drug Knowledge to Reduce the Risk of Opioid-Related Overdose and biospace
March 16, 2018
FDB announced the release of the FDB Opioid Risk Management Module™ that helps reduce the risk of opioid-related overdose and addiction potential.
Addressing the safety and risk management needs of small and medium sized businesses pharmaasia
August 11, 2017
By David Balderson, vice president global safety operations and Supriya Desai, global pharmacovigilance director, Sciformix Corporation